InceptionR’s Alnylam Pharmaceuticals ALNY Stock Holding History

InceptionR’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$691K	Buy	+2,296	New	+$693K	0.17%	228
2026 Q1	–	Sell	-2,415	Closed	-$960K	–	637
2025 Q4	$960K	Sell	2,415 -1,104	-31%	-$489K	0.27%	117
2025 Q3	$1.6M	Sell	3,519 -1,057	-23%	-$430K	0.39%	36
2025 Q2	$1.49M	Buy	4,576 +3,238	+242%	+$896K	0.35%	68
2025 Q1	$361K	Buy	+1,338	New	+$344K	0.11%	342
2024 Q4	–	Sell	-1,224	Closed	-$337K	–	605
2024 Q3	$337K	Sell	1,224 -4,173	-77%	-$1.09M	0.08%	425
2024 Q2	$1.31M	Buy	+5,397	New	+$852K	0.37%	65
2023 Q3	–	Sell	-1,279	Closed	-$243K	–	390
2023 Q2	$243K	Buy	+1,279	New	+$254K	0.13%	318

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's ALNY Position: Q2 2026 in Review

InceptionR opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 2,296 shares worth $691K. The stake represents 0.17% of the portfolio and ranks #228 among its holdings. This is a return to the name: InceptionR previously reported a position in ALNY as recently as Q4 2025.

InceptionR first reported a position in ALNY in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.6M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

InceptionR held 2,296 shares of Alnylam Pharmaceuticals worth $691K as of Q2 2026.
Alnylam Pharmaceuticals was a new InceptionR position in Q2 2026.
Alnylam Pharmaceuticals made up 0.17% of InceptionR's portfolio in Q2 2026, its #228 holding.
InceptionR first reported a position in Alnylam Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
InceptionR's Alnylam Pharmaceuticals position peaked at $1.6M in Q3 2025.
790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.